Condition: Brain Metastases · Sponsor: University of Alabama at Birmingham
Radiosurgery is the use of a focal high dose of radiation therapy to ablate or kill a tumor. This trial will enroll patients with brain metastases 4 cm or less in greatest diameter and will compare 0mm margin to a 2mm margin for treatment.
This description comes directly from the study's public registry record.
John Fiveash, MD · 205-975-0224 · jfiveash@uabmc.edu
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center | Birmingham, Alabama, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06857006